Profile data is unavailable for this security.
About the company
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
- Revenue in USD (TTM)2.67bn
- Net income in USD-637.32m
- Incorporated1975
- Employees8.03k
- LocationBio Rad Laboratories Inc1000 ALFRED NOBEL DRHERCULES 94547-1811United StatesUSA
- Phone+1 (510) 724-7000
- Fax+1 (510) 741-5817
- Websitehttps://www.bio-rad.com/
| Holder | Shares | % Held |
|---|---|---|
| CSS LLCas of 31 Dec 2023 | 1.81k | 0.04% |
| Buckingham Strategic Wealth LLCas of 31 Dec 2023 | 760.00 | 0.02% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 692.00 | 0.01% |
| Wells Fargo Clearing Services LLCas of 31 Dec 2023 | 170.00 | 0.00% |
| Whittier Trust Co.as of 31 Dec 2023 | 160.00 | 0.00% |
| Parametric Portfolio Associates LLCas of 31 Dec 2023 | 32.00 | 0.00% |
| JNBA Financial Advisors, Inc.as of 31 Dec 2023 | 2.00 | 0.00% |
| Securities America Advisors, Inc.as of 31 Dec 2023 | 0.00 | 0.00% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 0.00 | 0.00% |
